Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arya Biragyn

Showing results (31-40 of 83) with videos related to

Pageof 9
Sort By:
Blood|October 9, 2008
Dexamethasone augments CXCR4-mediated signaling in resting human T cells via the activation of the Src kinase LckManik C Ghosh, Dolgor Baatar, Gary Collins, et al.
Expert Review of Proteomics|June 22, 2005
Enrichment of low-molecular-weight proteins from biofluids for biomarker discoveryOleg Chertov, John T Simpson, Arya Biragyn, et al.
Expert Opinion on Biological Therapy|February 17, 2009
Potent human monoclonal antibodies against SARS CoV, Nipah and Hendra virusesPonraj Prabakaran, Zhongyu Zhu, Xiaodong Xiao, et al.
Blood|August 1, 2002
DNA vaccines encoding human immunodeficiency virus-1 glycoprotein 120 fusions with proinflammatory chemoattractants induce systemic and mucosal immune responsesArya Biragyn, Igor M Belyakov, Yen-Hung Chow, et al.
Journal of Leukocyte Biology|April 13, 2004
Genetic fusions with viral chemokines target delivery of nonimmunogenic antigen to trigger antitumor immunity independent of chemotaxisPier Adelchi Ruffini, Arya Biragyn, Marta Coscia, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 2013
Cancer-produced metabolites of 5-lipoxygenase induce tumor-evoked regulatory B cells via peroxisome proliferator-activated receptor αKatarzyna Wejksza, Catalina Lee-Chang, Monica Bodogai, et al.
Nature Communications|September 14, 2022
Cancer co-opts differentiation of B-cell precursors into macrophage-like cellsChen Chen, Bongsoo Park, Emeline Ragonnaud, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 18, 2013
Inhibition of breast cancer metastasis by resveratrol-mediated inactivation of tumor-evoked regulatory B cellsCatalina Lee-Chang, Monica Bodogai, Alejandro Martin-Montalvo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 10, 2007
Tumor-associated embryonic antigen-expressing vaccines that target CCR6 elicit potent CD8+ T cell-mediated protective and therapeutic antitumor immunityArya Biragyn, Roberta Schiavo, Purevdorj Olkhanud, et al.
Blood|June 12, 2004
Chemokine receptor-mediated delivery directs self-tumor antigen efficiently into the class II processing pathway in vitro and induces protective immunity in vivoArya Biragyn, Pier Adelchi Ruffini, Marta Coscia, et al.
Pageof 9

Showing results (31-40 of 83) with videos related to

Sort By:
Pageof 9
Blood|October 9, 2008
Dexamethasone augments CXCR4-mediated signaling in resting human T cells via the activation of the Src kinase LckManik C Ghosh, Dolgor Baatar, Gary Collins, et al.
Expert Review of Proteomics|June 22, 2005
Enrichment of low-molecular-weight proteins from biofluids for biomarker discoveryOleg Chertov, John T Simpson, Arya Biragyn, et al.
Expert Opinion on Biological Therapy|February 17, 2009
Potent human monoclonal antibodies against SARS CoV, Nipah and Hendra virusesPonraj Prabakaran, Zhongyu Zhu, Xiaodong Xiao, et al.
Blood|August 1, 2002
DNA vaccines encoding human immunodeficiency virus-1 glycoprotein 120 fusions with proinflammatory chemoattractants induce systemic and mucosal immune responsesArya Biragyn, Igor M Belyakov, Yen-Hung Chow, et al.
Journal of Leukocyte Biology|April 13, 2004
Genetic fusions with viral chemokines target delivery of nonimmunogenic antigen to trigger antitumor immunity independent of chemotaxisPier Adelchi Ruffini, Arya Biragyn, Marta Coscia, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 2013
Cancer-produced metabolites of 5-lipoxygenase induce tumor-evoked regulatory B cells via peroxisome proliferator-activated receptor αKatarzyna Wejksza, Catalina Lee-Chang, Monica Bodogai, et al.
Nature Communications|September 14, 2022
Cancer co-opts differentiation of B-cell precursors into macrophage-like cellsChen Chen, Bongsoo Park, Emeline Ragonnaud, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 18, 2013
Inhibition of breast cancer metastasis by resveratrol-mediated inactivation of tumor-evoked regulatory B cellsCatalina Lee-Chang, Monica Bodogai, Alejandro Martin-Montalvo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 10, 2007
Tumor-associated embryonic antigen-expressing vaccines that target CCR6 elicit potent CD8+ T cell-mediated protective and therapeutic antitumor immunityArya Biragyn, Roberta Schiavo, Purevdorj Olkhanud, et al.
Blood|June 12, 2004
Chemokine receptor-mediated delivery directs self-tumor antigen efficiently into the class II processing pathway in vitro and induces protective immunity in vivoArya Biragyn, Pier Adelchi Ruffini, Marta Coscia, et al.
Pageof 9